Picture of Star Combo Pharma logo

S66 — Star Combo Pharma News Story

0.000.00%
au flag iconLast trade - 00:00
Consumer CyclicalsSpeculativeMicro CapContrarian

Brief: Star Combo Pharma Says Qtrly Group Revenue Was A$5.0 Mln

May 3 (Reuters) - Star Combo Pharma Ltd  S66.AX :
    * S66 BUSINESS UPDATE Q3
    * RETAIL DIVISION OF STAR COMBO CONTINUED TO BE IMPACTED BY
COVID
PANDEMIC AS DECREASED TOURISM CONTINUED
    * QTRLY GROUP REVENUE WAS A$5.0M VERSUS A$6.1M
    * FY22 OUTLOOK POSITIVE FOR CORE OEM BUSINESS
    * WILL CONTINUE TO BE CONSTRAINED BY SUPPLY CHALLENGES
    * EXPECT INCREASE IN OUTPUT IN 1H2023

Source text for Eikon:  ID:nASX8gvVM2 
Further company coverage:  S66.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Star Combo Pharma

See all news